Nemes Rush Group’s Teladoc Health TDOC Stock Holding History

Nemes Rush Group’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.04K	Hold	359	–	–	﹤0.01%	730
2026 Q1	$1.96K	Hold	359	–	–	﹤0.01%	750
2025 Q4	$2.51K	Hold	359	–	–	﹤0.01%	702
2025 Q3	$2.77K	Sell	359 -23	-6%	-$180	﹤0.01%	582
2025 Q2	$3.33K	Hold	382	–	–	﹤0.01%	571
2025 Q1	$3.04K	Hold	382	–	–	﹤0.01%	577
2024 Q4	$3.47K	Sell	382 -18	-5%	-$174	﹤0.01%	575
2024 Q3	$6.04K	Buy	400 +18	+5%	+$149	﹤0.01%	449
2024 Q2	$3.74K	Sell	382 -18	-5%	-$220	﹤0.01%	484
2024 Q1	$6.04K	Buy	400 +18	+5%	+$327	﹤0.01%	485
2023 Q4	$8.23K	Hold	382	–	–	﹤0.01%	440
2023 Q3	$7.1K	Hold	382	–	–	﹤0.01%	440
2023 Q2	$9.67K	Buy	+382	New	+$9.61K	﹤0.01%	430

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Nemes Rush Group's TDOC Position: Q2 2026 in Review

Nemes Rush Group held its Teladoc Health (TDOC) position steady in Q2 2026 at 359 shares worth $3.04K. The position accounts for ﹤0.01% of the portfolio, ranked #730.

Nemes Rush Group first reported a position in TDOC in Q2 2023 and has held it in 13 quarters since. The position peaked at $9.67K in Q2 2023. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Nemes Rush Group held 359 shares of Teladoc Health worth $3.04K as of Q2 2026.
Nemes Rush Group left its Teladoc Health share count unchanged in Q2 2026.
Teladoc Health made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #730 holding.
Nemes Rush Group first reported a position in Teladoc Health in Q2 2023 and has held it in 13 quarters since.
Nemes Rush Group's Teladoc Health position peaked at $9.67K in Q2 2023.
348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.